The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO).
Updated guidelines incorporate recent advances to improve myelofibrosis diagnosis and management across German-speaking regions.
The 2025 update of the German ONKOPEDIA myelofibrosis guideline, developed by an international MPN expert panel (Germany, Austria, Switzerland), provides revised evidence-based recommendations for MF diagnosis and management incorporating recent therapeutic advances. This guideline update serves as a key clinical reference for MPN treatment decisions in German-speaking countries and beyond.
What the study was
- Study design
- Clinical practice guideline
- Population
- Patients with primary myelofibrosis (MPN)
- Category
- Treatment Innovation
- Maturity
- Potentially Practice-Changing
- Journal
- International Journal of Cancer
Why it surfaced
Authoritative DGHO guideline update for myelofibrosis 2025; high clinical relevance for MPN management. Companion paper 42324204 (PMF-specific section) counted in LOW.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.